OGN icon

Organon & Co

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 73.6%
Negative

Positive
Zacks Investment Research
7 days ago
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Negative
Zacks Investment Research
9 days ago
Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade
Organon (OGN) reached $10.84 at the closing of the latest trading day, reflecting a -1.54% change compared to its last close.
Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade
Positive
Zacks Investment Research
9 days ago
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?
Positive
Zacks Investment Research
16 days ago
Organon (OGN) Outperforms Broader Market: What You Need to Know
Organon (OGN) reached $10.35 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
Organon (OGN) Outperforms Broader Market: What You Need to Know
Negative
Zacks Investment Research
20 days ago
Here's Why Organon (OGN) Fell More Than Broader Market
Organon (OGN) closed the most recent trading day at $10.12, moving 2.79% from the previous trading session.
Here's Why Organon (OGN) Fell More Than Broader Market
Positive
Zacks Investment Research
21 days ago
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Neutral
Zacks Investment Research
26 days ago
Organon (OGN) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Organon (OGN) stood at $10.45, denoting a -3.69% move from the preceding trading day.
Organon (OGN) Stock Dips While Market Gains: Key Facts
Neutral
Business Wire
27 days ago
European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--European Commission Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars.
European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
Positive
Zacks Investment Research
1 month ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Neutral
Zacks Investment Research
1 month ago
Organon (OGN) Stock Declines While Market Improves: Some Information for Investors
Organon (OGN) concluded the recent trading session at $10.26, signifying a -1.06% move from its prior day's close.
Organon (OGN) Stock Declines While Market Improves: Some Information for Investors